Imago Biosciences Stock Price, News & Analysis
Company Description
Imago Biosciences (NASDAQ: IMGO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.2B.
IMGO stock has gained 80.7% over the past year.
This page provides a comprehensive overview of IMGO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Imago Biosciences (IMGO) stock. Over the past 12 months, the stock has gained 80.7%. At a market capitalization of $1.2B, IMGO is classified as a small-cap stock with approximately 33.8M shares outstanding.
Latest News
Imago Biosciences has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, clinical trial, earnings, conferences. View all IMGO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
IMGO Company Profile & Sector Positioning
Imago Biosciences (IMGO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.